Tegsedi (Inotersen) Drug Interactions: 7 Major, 212 Moderate
Tegsedi (Inotersen) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tegsedi. Always confirm against the full prescribing information.
100 interactions
Aceclofenac
The risk or severity of nephrotoxicity can be increased when Inotersen is combined with Aceclofenac.
Level 1 evidence
Acenocoumarol
The risk or severity of thrombocytopenia can be increased when Inotersen is combined with Acenocoumarol.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of thrombocytopenia can be increased when Inotersen is combined with Acetylsalicylic acid.
Level 1 evidence
Acyclovir
The risk or severity of nephrotoxicity can be increased when Inotersen is combined with Acyclovir.
Level 1 evidence
Adefovir dipivoxil
The risk or severity of nephrotoxicity can be increased when Inotersen is combined with Adefovir dipivoxil.
Level 1 evidence
Alendronic acid
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Inotersen is combined with Alendronic acid.
Level 2 evidence
Alteplase
The risk or severity of thrombocytopenia can be increased when Inotersen is combined with Alteplase.
Level 1 evidence
Amikacin
The risk or severity of nephrotoxicity can be increased when Inotersen is combined with Amikacin.
Level 1 evidence
Amiodarone
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Amiodarone.
Level 2 evidence
Amphotericin B
The risk or severity of nephrotoxicity can be increased when Inotersen is combined with Amphotericin B.
Level 1 evidence
Anagrelide
The risk or severity of thrombocytopenia can be increased when Inotersen is combined with Anagrelide.
Level 1 evidence
Antipyrine
The risk or severity of nephrotoxicity can be increased when Inotersen is combined with Antipyrine.
Tegsedi (Inotersen) has 715 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Tegsedi (Inotersen) has 7 major, 212 moderate, and 496 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tegsedi. Always confirm against the full prescribing information.